These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 20350768

  • 1. Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression.
    Pott Godoy MC, Ferrari CC, Pitossi FJ.
    J Neuroimmunol; 2010 May; 222(1-2):29-39. PubMed ID: 20350768
    [Abstract] [Full Text] [Related]

  • 2. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
    De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F.
    Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
    [Abstract] [Full Text] [Related]

  • 3. Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice.
    Bian MJ, Li LM, Yu M, Fei J, Huang F.
    Brain Res; 2009 Dec 11; 1302():256-64. PubMed ID: 19631617
    [Abstract] [Full Text] [Related]

  • 4. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
    Ferrari CC, Pott Godoy MC, Tarelli R, Chertoff M, Depino AM, Pitossi FJ.
    Neurobiol Dis; 2006 Oct 11; 24(1):183-93. PubMed ID: 16901708
    [Abstract] [Full Text] [Related]

  • 5. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S, Moon M, Park S.
    J Endocrinol; 2009 Sep 11; 202(3):431-9. PubMed ID: 19570816
    [Abstract] [Full Text] [Related]

  • 6. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A, Joniec I, Kurkowska-Jastrzebska I, Przybyłkowski A, Gromadzka G, Członkowska A, Członkowski A.
    Neuroimmunomodulation; 2007 Sep 11; 14(5):255-65. PubMed ID: 18196934
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.
    Barnum CJ, Eskow KL, Dupre K, Blandino P, Deak T, Bishop C.
    Neuroscience; 2008 Sep 22; 156(1):30-41. PubMed ID: 18687386
    [Abstract] [Full Text] [Related]

  • 11. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.
    Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE.
    Neurobiol Dis; 2005 Nov 22; 20(2):360-71. PubMed ID: 16242641
    [Abstract] [Full Text] [Related]

  • 12. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M, Kondo T, Mizuno Y, Nagatsu T.
    Neurosci Lett; 2007 Feb 27; 414(1):94-7. PubMed ID: 17196747
    [Abstract] [Full Text] [Related]

  • 13. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K, Finkelstein DI, Gundlach AL.
    Brain Res; 2009 May 19; 1271():83-94. PubMed ID: 19328193
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 19; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 15. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
    Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G.
    J Neurochem; 2007 Mar 19; 100(5):1375-86. PubMed ID: 17254027
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FK506 protects against various immune responses and secondary degeneration following cerebral ischemia.
    Brecht S, Waetzig V, Hidding U, Hanisch UK, Walther M, Herdegen T, Neiss WF.
    Anat Rec (Hoboken); 2009 Dec 19; 292(12):1993-2001. PubMed ID: 19728359
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
    Hébert G, Mingam R, Arsaut J, Dantzer R, Demotes-Mainard J.
    Brain Res Mol Brain Res; 2005 Aug 18; 138(2):156-63. PubMed ID: 15922486
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.